Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Aug 18, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Net Equity Issued and Repurchased (2022 - 2025)

Raphael Pharmaceutical (RAPH) posted Net Equity Issued and Repurchased of $3000.0 for Q4 2025, down 98.75% sequentially from $240000.0 in Q1 2025.

Raphael Pharmaceutical (RAPH) Net Equity Issued and Repurchased (2022 - 2025) Analysis & Trends

Raphael Pharmaceutical has reported Net Equity Issued and Repurchased for 4 years, with the latest figure at $3000.0 in Q4 2025.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $3000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $243000.0 (down 13.21% YoY) and the FY2025 annual result came in at $243000.0, down 13.21% from the prior year.
  • Net Equity Issued and Repurchased eased to $3000.0 in Q4 2025 per RAPH's latest filing, from $240000.0 in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $812000.0 in Q3 2023 and troughed at $3000.0 in Q4 2025.
  • A 4-year average of $209428.6 and a median of $112000.0 in 2022 frame the typical range for Net Equity Issued and Repurchased.
  • The sharpest annual moves came in 2023 and 2025: Net Equity Issued and Repurchased surged 625.0% in 2023, then soared 33.33% in 2025.
  • Over 4 years, Net Equity Issued and Repurchased stood at $112000.0 in 2022, then slumped by 83.04% to $19000.0 in 2023, then surged by 426.32% to $100000.0 in 2024, then tumbled by 97.0% to $3000.0 in 2025.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $3000.0, $240000.0, and $100000.0 for Q4 2025, Q1 2025, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - -
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn -
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn -
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - -
10 Raphael Pharmaceutical 28.25 Mn 28.25 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 3,000.00
Dec 31, 2025 3,000.00
Mar 31, 2025 240,000.00
Mar 31, 2025 240,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 180,000.00
Mar 31, 2024 180,000.00
Dec 31, 2023 19,000.00
Dec 31, 2023 19,000.00
Sep 30, 2023 812,000.00
Sep 30, 2023 812,000.00
Sep 30, 2022 112,000.00
Sep 30, 2022 112,000.00